Iron Metabolism in Cardiovascular Disease

Area of Science:

• Cardiovascular Medicine
• Cellular Metabolism
• Hematology

Background:

• Iron is crucial for cardiomyocyte energy production and function.
• Systemic and intracellular iron regulation involves complex protein interactions.
• Iron dysregulation leads to various cardiovascular diseases, including heart failure.

Purpose of the Study:

• To discuss the role of iron dysregulation in cardiovascular diseases.
• To review therapeutic strategies for iron deficiency in heart failure.
• To explore future perspectives in iron metabolism and cardiovascular health.

Main Methods:

• Review of existing literature on iron metabolism and cardiovascular disease.
• Analysis of recent clinical trials on intravenous iron supplementation for heart failure.
• Discussion of emerging biomarkers for iron deficiency diagnosis.

Main Results:

• Iron deficiency or overload significantly impacts cardiovascular health.
• Intravenous iron supplementation shows potential in improving heart failure outcomes.
• Soluble transferrin receptors are promising biomarkers for iron deficiency anemia.

Conclusions:

• Iron dysregulation is a key factor in cardiovascular pathology.
• Targeted iron therapy offers a promising approach for managing heart failure.
• Further research is needed to fully understand and manage iron's role in cardiovascular health.